NeuroBo Pharmaceuticals
(NASDAQ:NRBO)
$3.74
0.34[10.00%]
At close: Apr 17
$3.74
0[0.00%]
After Hours: 9:27AM EDT
OverviewNewsEarningsGuidanceDividendsAnalyst RatingsInsider TradesShort Interest

NeuroBo Pharmaceuticals Stock (NASDAQ:NRBO), Quotes and News Summary

NeuroBo Pharmaceuticals Stock (NASDAQ: NRBO) stock price, news, charts, stock research, profile.

Open$3.690
Close$3.460
Volume / Avg.11.485K / 1.307M
Day Range3.460 - 3.690
52 Wk Range2.889 - 7.599
Market Cap$18.349M
P/E Ratio-
Dividend Yield-
ExchangeNASDAQ
RSI
34
Short Interest
2.98%
Days to Cover1.33

Recent News

Dow Jumps 250 Points; Honeywell Issues Weak Forecast
U.S. stocks traded higher toward the end of trading, with the Dow Jones index gaining around 250 points on Thursday. The Dow traded up 0.66% to 38,403.91 while the NASDAQ rose 1.01% to 15,316.80. The S&P 500 also rose, gaining, 0.87% to 4,887.70.
Avi Kapoor
Why C.H. Robinson Shares Are Trading Lower By Over 12%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Shares of C.H. Robinson Worldwide, Inc. (NASDAQ: CHRW) fell sharply during Thursday’s session after the company reported worse-than-expected fourth-quarter financial results.
Avi Kapoor
Crude Oil Gains 1%; ISM Manufacturing PMI Tops Expectations
U.S. stocks traded higher midway through trading, with the S&P 500 gaining around 0.5% on Thursday. The Dow traded up 0.23% to 38,238.99 while the NASDAQ rose 0.54% to 15,245.46. The S&P 500 also rose, gaining, 0.48% to 4,868.71.
Avi Kapoor
-%

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change
Analyst Rating
12345
4.0
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell
About NeuroBo Pharmaceuticals Inc
Sector
Health Care
Industry
Biotechnology
NeuroBo Pharmaceuticals Inc is a clinical-stage biotechnology company focused predominantly on devel...
Show More

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
NRBO
VINC

FAQ

Q

How do I buy NeuroBo Pharmaceuticals (NRBO) stock?

A

You can purchase shares of NeuroBo Pharmaceuticals (NASDAQ: NRBO) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are NeuroBo Pharmaceuticals's (NRBO) competitors?

A

Other companies in NeuroBo Pharmaceuticals’s space includes: Vincerx Pharma (NASDAQ:VINC), Galecto (NASDAQ:GLTO), Immuron (NASDAQ:IMRN), Dominari Holdings (NASDAQ:DOMH) and Imunon (NASDAQ:IMNN).

Q

What is the target price for NeuroBo Pharmaceuticals (NRBO) stock?

A

The latest price target for NeuroBo Pharmaceuticals (NASDAQ: NRBO) was reported by Ladenburg Thalmann on Wednesday, December 7, 2022. The analyst firm set a price target for 6.00 expecting NRBO to rise to within 12 months (a possible 60.43% upside). 0 analyst firms have reported ratings in the last year.

Q

Current Stock Price for NeuroBo Pharmaceuticals (NRBO)?

A

The stock price for NeuroBo Pharmaceuticals (NASDAQ: NRBO) is $3.74 last updated April 17, 2024 at 9:27 AM EDT.

Q

Does NeuroBo Pharmaceuticals (NRBO) pay a dividend?

A

There are no upcoming dividends for NeuroBo Pharmaceuticals.

Q

When is NeuroBo Pharmaceuticals (NASDAQ:NRBO) reporting earnings?

A

NeuroBo Pharmaceuticals’s Q1 earnings are confirmed for Friday, May 10, 2024.

Q

Is NeuroBo Pharmaceuticals (NRBO) going to split?

A

There is no upcoming split for NeuroBo Pharmaceuticals.

Q

What sector and industry does NeuroBo Pharmaceuticals (NRBO) operate in?

A

NeuroBo Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

People Also Watch